ARVN
Price
$18.39
Change
-$0.71 (-3.72%)
Updated
Dec 18, 04:06 PM (EDT)
75 days until earnings call
PHVS
Price
$18.50
Change
+$0.01 (+0.05%)
Updated
Dec 18, 04:59 PM (EDT)
127 days until earnings call
Ad is loading...

ARVN vs PHVS

Header iconARVN vs PHVS Comparison
Open Charts ARVN vs PHVSBanner chart's image
Arvinas
Price$18.39
Change-$0.71 (-3.72%)
Volume$1K
CapitalizationN/A
Pharvaris
Price$18.50
Change+$0.01 (+0.05%)
Volume$4.8K
CapitalizationN/A
ARVN vs PHVS Comparison Chart
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. PHVS commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and PHVS is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ARVN: $19.10 vs. PHVS: $18.49)
Brand notoriety: ARVN and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 195% vs. PHVS: 50%
Market capitalization -- ARVN: $1.31B vs. PHVS: $1B
ARVN [@Biotechnology] is valued at $1.31B. PHVS’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARVN and PHVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish while PHVS’s TA Score has 3 bullish TA indicator(s).

  • ARVN’s TA Score: 4 bullish, 6 bearish.
  • PHVS’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than PHVS.

Price Growth

ARVN (@Biotechnology) experienced а -22.33% price change this week, while PHVS (@Biotechnology) price change was +1.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

ARVN is expected to report earnings on Mar 03, 2025.

PHVS is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($1.31B) has a higher market cap than PHVS($1B). PHVS YTD gains are higher at: -34.082 vs. ARVN (-53.596). PHVS has higher annual earnings (EBITDA): -127.53M vs. ARVN (-350.6M). ARVN has more cash in the bank: 1.12B vs. PHVS (305M). PHVS has less debt than ARVN: PHVS (117K) vs ARVN (1.5M). ARVN has higher revenues than PHVS: ARVN (161M) vs PHVS (0).
ARVNPHVSARVN / PHVS
Capitalization1.31B1B131%
EBITDA-350.6M-127.53M275%
Gain YTD-53.596-34.082157%
P/E RatioN/AN/A-
Revenue161M0-
Total Cash1.12B305M368%
Total Debt1.5M117K1,282%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNPHVS
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend 15 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSSAX30.36N/A
N/A
Emerald Finance & Bking Innovt Fd A
EDICX10.88-0.02
-0.18%
Eaton Vance Global Income Builder C
DDICX15.04-0.07
-0.46%
Delaware Wealth Builder C
FSPTX38.01-0.24
-0.63%
Fidelity Select Technology
CSGYX30.93-0.35
-1.12%
Columbia Small Cap Growth Inst3

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ABCL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
+0.58%
ABCL - ARVN
50%
Loosely correlated
-2.45%
CRBU - ARVN
49%
Loosely correlated
+1.57%
SNDX - ARVN
48%
Loosely correlated
-1.16%
AURA - ARVN
47%
Loosely correlated
-2.47%
AXON - ARVN
46%
Loosely correlated
-2.09%
More